- Home
- AMAL vs AVDL Comparison
AMAL vs AVDL Comparison
Compare AMAL & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMAL
- AVDL
- Stock Information
- Founded
- AMAL 1923
- AVDL 2015
- Country
- AMAL United States
- AVDL Ireland
- Employees
- AMAL N/A
- AVDL N/A
- Industry
- AMAL Commercial Banks
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- AMAL Finance
- AVDL Health Care
- Exchange
- AMAL Nasdaq
- AVDL Nasdaq
- Market Cap
- AMAL 867.2M
- AVDL 784.6M
- IPO Year
- AMAL 2018
- AVDL 1996
- Fundamental
- Price
- AMAL $30.28
- AVDL $9.39
- Analyst Decision
- AMAL Buy
- AVDL Strong Buy
- Analyst Count
- AMAL 3
- AVDL 7
- Target Price
- AMAL $36.50
- AVDL $18.86
- AVG Volume (30 Days)
- AMAL 178.4K
- AVDL 1.3M
- Earning Date
- AMAL 04-24-2025
- AVDL 05-07-2025
- Dividend Yield
- AMAL 1.85%
- AVDL N/A
- EPS Growth
- AMAL 9.81
- AVDL N/A
- EPS
- AMAL 3.36
- AVDL N/A
- Revenue
- AMAL $303,970,000.00
- AVDL $194,450,000.00
- Revenue This Year
- AMAL $12.20
- AVDL $50.53
- Revenue Next Year
- AMAL $13.99
- AVDL $32.33
- P/E Ratio
- AMAL $9.01
- AVDL N/A
- Revenue Growth
- AMAL 7.13
- AVDL 252.64
- 52 Week Low
- AMAL $24.02
- AVDL $6.38
- 52 Week High
- AMAL $38.19
- AVDL $17.85
- Technical
- Relative Strength Index (RSI)
- AMAL 63.79
- AVDL 64.66
- Support Level
- AMAL $28.31
- AVDL $8.55
- Resistance Level
- AMAL $30.56
- AVDL $9.98
- Average True Range (ATR)
- AMAL 0.91
- AVDL 0.51
- MACD
- AMAL 0.38
- AVDL 0.10
- Stochastic Oscillator
- AMAL 92.95
- AVDL 72.04
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.